Globe Life is set to grow on well-performing American Income and Liberty National divisions, higher invested assets and a strong liquidity position.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Globe Life Inc. (NYSE:GL ) Q2 2025 Earnings Conference Call July 24, 2025 11:00 AM ET Company Participants Frank Martin Svoboda - Co-Chairman & Co-CEO James Matthew Darden - Co-Chairman & Co-CEO Stephen Mota - Senior Director of Investor Relations Thomas Peter Kalmbach - Executive VP & CFO Conference Call Participants Andrew Scott Kligerman - TD Cowen, Research Division Elyse Beth Greenspan - Wells Fargo Securities, LLC, Research Division Jack Matten - BMO Capital Markets Equity Research Jamminder Singh Bhullar - JPMorgan Chase & Co, Research Division John Bakewell Barnidge - Piper Sandler & Co., Research Division Mark Douglas Hughes - Truist Securities, Inc., Research Division Ryan Joel Krueger - Keefe, Bruyette, & Woods, Inc., Research Division Suneet Laxman L. Kamath - Jefferies LLC, Research Division Thomas George Gallagher - Evercore ISI Institutional Equities, Research Division Wesley Collin Carmichael - Autonomous Research US LP Wilma Carter Jackson Burdis - Raymond James & Associates, Inc., Research Division Operator Hello, and welcome to Globe Life Inc. Second Quarter Earnings Release Call.
GL's Q2 earnings increase 10% as strong Life and Health premiums offset declines in investment income and rising expenses.
Globe Life (GL) came out with quarterly earnings of $3.27 per share, beating the Zacks Consensus Estimate of $3.25 per share. This compares to earnings of $2.97 per share a year ago.
Investors need to pay close attention to GL stock based on the movements in the options market lately.
Get a deeper insight into the potential performance of Globe Life (GL) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Globe Life (GL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Globe Life is set to grow on well-performing American Income and Liberty National divisions, higher invested assets and a strong liquidity position.
I highlight four American SWAN stocks - Realty Income, Alphabet, Globe Life, and Thermo Fisher Scientific - offering stress-free, blue-chip investment opportunities. Each company boasts strong management, robust balance sheets, consistent earnings, and attractive valuations, trading 18-24% below my fair value estimates. These stocks offer a blended 1.8% yield, low payout ratios, and A or AA credit ratings, supporting reliable dividend growth and low long-term risk.
The Magnificent Seven are often in the spotlight, but not because of any major shifts in their businesses. Some could call it a proverbial flip of the narrative switch to shine the lights on the usual suspects to stir up some fresh buying activity.